Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Ohio State University Comprehensive Cancer Center
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Richard Goldberg, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01652196
First received: July 25, 2012
Last updated: March 18, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)